Lebwohl, M., R. B. Warren, S. Imafuku, J. Bagel, A. W. Armstrong, T. Passeron, S. Banerjee, M. J. Colombo, T. Scharnitz, K. Hoyt, D. Thaci, and A. Blauvelt. “Deucravacitinib Long-Term Efficacy Through 4 Years in Week 16 Placebo Crossover Patients in the Phase 3 POETYK PSO-1, PSO-2, and LTE Program”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 4, July 2024, p. s408, doi:10.25251/skin.8.supp.408.